期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 18, 期 5, 页码 1632-1636出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2008.01.060
关键词
cell-penetrating peptide; prodrug; chemotherapy; doxorubicin
资金
- NCI NIH HHS [R01 CA094193, R01 CA094193-02, R01 CA094193-03, R01 CA094193-01A2, R01 CA094193-04, CA 094193] Funding Source: Medline
Tumor targeting peptides are promising vehicles for site-directed cancer therapy. Pep42, a cyclic 13-mer oligopeptide that specifically binds to glucose-regulated protein 78 (GRP78) and internalized into cancer cells, represents an excellent vehicle for tumor cell-specific chemotherapy. Here, we report the synthesis and evaluation of Pep42-prodrug conjugates that contain a cathepsin B-cleavable linker, resulting in the traceless release of drug inside the cancer cells. (c) 2008 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据